Read Larry Connors' blog – Short Term Trading Strategies
HearstArgyle Television Inc. (NYSE: HTV | Quote | Chart | News | PowerRating) together with its subsidiaries, engages in the ownership and operation of network-affiliated television stations in the United States. As of December 31, 2007, the company owned and operated 26 television stations, including 10 stations affiliated with NBC, 12 ABC affiliated stations, 2 CBS affiliated station, 1 CW affiliated station, and 1 station affiliated with MyNetworkTV. The company provides free over-the-air programming to its television viewing audiences. Its programming includes three components, which include programs produced by networks with which it is affiliated, such as ABC's Desperate Housewives, NBC's Law and Order and CBS' CSI: Crime Scene Investigation, and special event programs like The Academy Awards and the Olympics; programs that it produces, such as local news, weather, sports and entertainment; and first-run syndicated programs that it acquires, such as The Oprah Winfrey Show and Entertainment Tonight. Its stations also provide public service announcements and political coverage, as well as sponsor community service projects and other public initiatives. The company was founded in 1994 and is headquartered in New York, New York. Hearst-Argyle Television, Inc. is a subsidiary of The Hearst Corporation. With 93.88 million shares outstanding and 2.73 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of HTV. According to quarterly data provided by the SEC, there were still 10,551 shares of HTV that were failing-to-deliver as of September 11, 2007.
Ener1 Inc. (AMEX: HEV | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the development and marketing of Lithium-ion batteries, fuel cells, and nanotechnology-related manufacturing processes and materials. It operates in three segments: Battery, Fuel Cell, and Nanotechnology. The Battery segment develops and markets Li-ion batteries and battery packs for hybrid electric vehicles, plug-in hybrid electric vehicles, electric vehicles, and other markets, such as non-automotive transportation and military markets. The Fuel Cell segment produces fuel cell products and provides fuel cell related technical services. The nanotechnology segment focuses on the research and development its vapor deposition and solidification and high pressure vapor deposition solidification processes. These processes have applications in thin batteries and for corrosive-proof, metal-ceramic composite, heat resisting, heat-resistant, wear-proof, and other coatings for battery and non-battery applications. Ener1's customers include auto, truck, and bus manufacturers and their tier one suppliers, and departments of the U.S. government. The company was founded in 1985. It was formerly known as Boca Research, Inc. and changed its name to Ener1, Inc. in 2002. The company is headquartered in New York, New York. With 93.19 million shares outstanding and 8.84 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of HEV.
Lipid Sciences Inc. (NASDAQ: LIPD | Quote | Chart | News | PowerRating) a development-stage biotechnology company, engages in the research and development of products and processes to treat medical indications, such as cardiovascular diseases and viral infections in which lipids or fat components play a key role. Its technologies are based on a patented process that selectively removes lipids, such as cholesterol from targeted lipoproteins or viruses circulating in blood plasma without disrupting the nontargeted plasma proteins function. The company focuses on applications of its technologies in two areas, including cardiovascular disease using its high-density lipoproteins (HDL) therapy platform, and viral infections using its viral immunotherapy platform. The HDL therapy platform includes HDL selective delipidation, as well as HDL mimetic peptides, which consists of a sequence of amino acids that mimic the critical functional characteristics of Apolipoprotein A-I, a key protein component of HDL. This platform focuses on developing treatments for the reversal of atherosclerosis, which is the primary cause of heart attacks, strokes, and peripheral vascular disease. The viral immunotherapy platform focuses on the removal of lipid coatings from lipid-enveloped viruses and other lipid-containing infectious agents, such as human immunodeficiency virus, hepatitis B, and hepatitis C by the application of lipid sciences' delipidation technologies. It has a collaborative research and license agreement with Elanco Animal Health to research, develop, manufacture, and sell immunological products for animal health applications. The company, formerly known as NZ Corporation, was founded in 1908 and is headquartered in Pleasanton, California. With 37.13 million shares outstanding and 54,000 shares declared short as of July 2008, there is no longer a failure to deliver in shares of LIPD. According to quarterly data provided by the SEC, there were still 19,571 shares of LIPD that were failing-to-deliver as of September 28, 2007.
Quality Systems Inc. (NASDAQ: QSII | Quote | Chart | News | PowerRating) engages in the development and marketing of healthcare information systems in the United States. Its system automates various aspects of medical and dental practices, and networks of practices, such as physician hospital organizations and management service organizations, ambulatory care centers, community health centers, and medical and dental schools. The company offers proprietary electronic medical records software and practice management systems under the NextGen3 product name. The product categories of the NextGen suite include electronic medical records, enterprise practice management, enterprise appointment scheduling, enterprise master patient index, NextGen image control system, managed care server, electronic data interchange, system interfaces, Internet operability, and a patient-centric and provider-centric Web portal solution. It also offers NextGen Express designed for small practices and NextGen Community Health Solution; and revenue cycle management services under the Practice Solutions name, which include billing and collections services for medical practices. In addition, Quality Systems provides hardware and software installation, maintenance and support services, system training, and electronic data interchange services. The company was founded in 1974 and is headquartered in Irvine, California. With 27.45 million shares outstanding and 5.77 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of QSII. According to quarterly data provided by the SEC, there were still 34,967 shares of QSII that were failing-to-deliver as of September 28, 2007.
ShengdaTech Inc. (NASDAQ: SDTH | Quote | Chart | News | PowerRating) engages in developing, manufacturing, and marketing nano precipitated calcium carbonate (NPCC) products. Its NPCC products are used in paper, paints, rubber, plastic, tire, and polyvinyl chloride building materials industries. The company also offers coal based chemicals, including ammonium bicarbonate used in nitrogenous fertilizers; liquid ammonia; methanol, which is used in chemical, pharmaceutical, light, and textile industries, as well as an alternative to fossil fuel; and melamine, an intermediate product of resin. Its coal based chemicals are also used as raw materials for the production of organic and inorganic chemical products, including formaldehyde and pesticides. Shengdatech, Inc. offers its products to the manufacturers and distributors of agrochemicals primarily in Shandong and other parts of northern China. The company was founded in 2005 and is based in Tai'an City, China. With 54.2 million shares outstanding and 4.73 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of SDTH. According to quarterly data provided by the SEC, there were still 110,805 shares of SDTH that were failing-to-deliver as of September 28, 2007.
Stereotaxis Inc. (NASDAQ: STXS | Quote | Chart | News | PowerRating) designs, manufactures, and markets cardiology instrument control system for use in hospital's interventional surgical suite and interventional lab to treat arrhythmias and coronary artery disease in the United States, Canada, Europe, and internationally. The company offers NIOBE System that allows physicians to navigate proprietary catheters, guidewires, and delivery devices through the blood vessels and chambers of the heart to treatment sites; and NAVIGANT, an advanced user interface or physician control center, which physicians use to visualize and track procedures and to provide instrument control commands that govern the motion of the working tip of the catheter, guidewire, or delivery device. The company also provides ODYSSEY information management system that consolidates the multiple sources of diagnostic and imaging information found in the interventional lab into a large-screen user interface with single mouse control, which is connected through a private network line to other interventional labs or to a remote clinical call center; and CARDIODRIVE, an automated catheter advancement system used to remotely advance and retract the catheter in the patient's heart. Stereotaxis markets its products through a direct sales force of senior sales specialists, distributors, clinical specialists, and sales agents. It has strategic partnership with Siemens AG Medical Solutions, Philips Medical Systems, and Biosense Webster, Inc. The company was founded in 1990 and is based in St. Louis, Missouri. With 37.19 million shares outstanding and 5.91 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of STXS. According to quarterly data provided by the SEC, there were still 27,696 shares of STXS that were failing-to-deliver as of September 26, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,100,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
